NCT04629885View on ClinicalTrials.gov

Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

May 3, 2016

Primary Completion Date

May 3, 2017

Study Completion Date

May 3, 2017

Conditions
Vulvovaginal Atrophy
Interventions
DRUG

Oxytocin 400 IU vaginal gel

DRUG

Placebo

Matching placebo gel with identical appearance to the test product, used as reference treatment.

Trial Locations (3)

14186

Kvinnoforskningsenheten K59, Karolinska Universitetssjukhuset, Huddinge

75185

Kvinnokliniken, Akademiska sjukhuset, Uppsala

90185

Kvinnokliniken, Norrlands Universitetssjukhus, Umeå

Sponsors
All Listed Sponsors
lead

PepTonic Medical AB

INDUSTRY

NCT04629885 - Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms | Biotech Hunter | Biotech Hunter